LG Chem has secured a unique R&D potential which was approved for the first time in Korea for new drug by the FDA in USA. It has continued to grow as a global pharmaceutical company by expanding pipelines to develop new chemicals with c investment and R&D competence. LG Chem has studied hyaluronic acid products
since 1990. It launched solutions used
for ophthalmic surgery in 1995, and a drug for osteoarthritis in 2005, using
hyaluronic acid ingredients.